Thyroid nodule as a first manifestation of Hodgkin lymphoma–report of two cases and literature review

Diagnostic Pathology

Marek Ruchala³  Jan Breborowicz¹  Przemyslaw Majewski²  Malgorzata Szkudlarek³  Ewelina Szczepanek-Parulska³ 

[1] Department of Oncology, Poznan University of Medical Sciences, Poznan, Poland;Department of Clinical Pathology, Poznan University of Medical Sciences, Poznan, Poland;Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland

关键词: Reed-Sternberg cells;    Fine-needle aspiration biopsy (FNAB);    Hodgkin lymphoma;    Thyroid nodule;   

Others  :  806150
DOI  :  10.1186/1746-1596-8-116

 received in 2013-04-04, accepted in 2013-06-30,  发布年份 2013

【 摘 要 】

Lymphomas account for less than 5% of thyroid malignant lesions. Vast majority of them are B-cell non-Hodgkin lymphomas (NHL), while Hodgkin lymphoma (HL) is extremely rare. Here we present two cases of HL, at baseline manifesting as a thyroid lesion. First patient, 29-year-old pregnant female, initially suspected for metastatic medullary thyroid cancer, was eventually diagnosed with mixed cellularity type of thyroid HL. Second patient, 22-year-old woman with suspicion of advanced thyroid cancer, was in the end diagnosed with an extra-lymphatic classical HL of the thyroid. In both cases, despite repeated fine-needle aspiration biopsy, cytological examination gave inconclusive or misleading results. On histopathological examination, thyroid tumor cells were positive for CD15 and CD30 antigen, which is typical for Reed-Sternberg cells. In the report authors also discuss difficulties in management as well as potential importance of novel methods such as FISH, PCR and other molecular techniques in diagnostics of thyroid lymphomas.

【 授权许可】

   
2013 Szczepanek-Parulska et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Mani H, Jaffe ES: Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma 2009, 9(3):206-216.
• [2]Ilica AT, Kocacelebi K, Savas R, Ayan A: Imaging of extranodal lymphoma with PET/CT. Clin Nucl Med 2011, 36(10):e127-e138.
• [3]Dedecjus M, Kedzierska A, Kozak J, Kordek R, Brzezinski J: A rare case of Hodkin’s lymphoma of the mediastinum imitating retrosternal goiter–retrospective analysis of the diagnostic process. Pol Przegl Chir 2012, 84(7):363-366.
• [4]Weber AL, Rahemtullah A, Ferry JA: Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am 2003, 13(3):371-392.
• [5]Hart S, Horsman JM, Radstone CR, Hancock H, Goepel JR, Hancock BW: Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971–2000). Clin Oncol (R Coll Radiol) 2004, 16(3):186-192.
• [6]Graff-Baker A, Sosa JA, Roman SA: Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment. Curr Opin Oncol 2010, 22(1):17-22.
• [7]Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma K, Sugawara M: Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993, 3(2):93-99.
• [8]Wang SA, Rahemtullah A, Faquin WC, Roepke J, Harris NL, Hasserjian RP: Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol 2005, 18(12):1577-1584.
• [9]Ruchala M, Szczepanek E: Thyroid ultrasound - a piece of cake? Endokrynol Pol 2010, 61(3):330-344.
• [10]Freeman C, Berg JW, Cutler SJ: Occurrence and prognosis of extranodal lymphomas. Cancer 1972, 29(1):252-260.
• [11]Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U: Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin’s disease. Radiol Clin North Am 2007, 45(4):697-709. vii
• [12]Forconi F, Bocchia M, Marconcini S, Bigazzi C, Milani M, Fraternali-Orcioni G, Lauria F: CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland. Haematologica 1999, 84(10):946-948.
• [13]Gupta N, Nijhawan R, Srinivasan R, Rajwanshi A, Dutta P, Bhansaliy A, Sharma SC: Fine needle aspiration cytology of primary thyroid lymphoma: a report of ten cases. Cytojournal 2005, 2:21.
• [14]Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL: Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000, 24(5):623-639.
• [15]Aozasa K, Tsujimoto M, Sakurai M, Honda M, Yamashita K, Hanada M, Sugimoto A: Non-Hodgkin’s lymphomas in Osaka, Japan. Eur J Cancer Clin Oncol 1985, 21(4):487-492.
• [16]Enrique A, Quesada JL, Lorente J, Lopez D: Hodgkin and Non-Hodgkin lymphomas in otorhinolaryngology. Acta Otorrinolaringol Esp 2004, 55(8):387-389.
• [17]Pedersen RK, Pedersen NT: Primary non-Hodgkin’s lymphoma of the thyroid gland: a population based study. Histopathology 1996, 28(1):25-32.
• [18]Vianna DM, Curioni OA, Franca LJ, de Paiva DL, Pompeu BF, Dedivitis RA, Rapoport A: The histological rarity of thyroid cancer. Braz J Otorhinolaryngol 2012, 78(4):48-51.
• [19]Ochs RC, Bagg A: Molecular genetic characterization of lymphoma: application to cytology diagnosis. Diagn Cytopathol 2012, 40(6):542-555.
• [20]Watanabe N, Noh JY, Narimatsu H, Takeuchi K, Yamaguchi T, Kameyama K, Kobayashi K, Kami M, Kubo A, Kunii Y, Shimizu T, Mukasa K, Otsuka F, Miyara A, Minagawa A, Ito K: Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto’s disease. Br J Haematol 2011, 153(2):236-243.
• [21]Liso A, Capello D, Marafioti T, Tiacci E, Cerri M, Distler V, Paulli M, Carbone A, Delsol G, Campo E, Pileri S, Pasqualucci L, Gaidano G, Falini B: Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 2006, 108(3):1013-1020.
• [22]Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, Berger F, Ducottet X, Martin C, Salles G, Orgiazzi J, Coiffier B: Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002, 87(1):105-111.
• [23]Nix P, Nicolaides A, Coatesworth AP: Thyroid cancer review 2: management of differentiated thyroid cancers. Int J Clin Pract 2005, 59(12):1459-1463.
• [24]Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT Jr: Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer 1982, 50(12):2699-2707.
• [25]Engert A, Eichenauer DA, Dreyling M, Group EGW: Hodgkin’s lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(Suppl 4):108-109.
• [26]Li Y, Wang XB, Tian XY, Li B, Li Z: Unusual primary osseous Hodgkin lymphoma in rib with associated soft tissue mass: a case report and review of literature. Diagn Pathol 2012, 7:64.
• [27]Ma Y, Li Q, Cui W, Miao N, Liu X, Zhang W, Zhang C, Wang J: Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems. Diagn Pathol 2012, 7:120.
• [28]Hafez MT, Hegazy MA, Abd Elwahab K, Arafa M, Abdou I, Refky B: Metastatic rhabdomyosarcoma of the thyroid gland, a case report. Head Neck Oncol 2012, 4:27.
• [29]Amal B, El Fatemi H, Souaf I, Moumna K, Affaf A: A rare primary tumor of the thyroid gland: report a new case of leiomyosarcoma and literature review. Diagn Pathol 2013, 8:36.
• [30]Shrestha M, Sridhara SK, Leo LJ, Coppit GL III, Ehrhardt NM: Primary squamous cell carcinoma of the thyroid gland: a case report and review. Head Neck 2012. [Epub ahead of print]
• [31]Petronella P, Scorzelli M, Luise R, Iannaci G, Sapere P, Ferretti M, Costanzo RM, Freda F, Canonico S, Rossiello R: Primary thyroid angiosarcoma: an unusual localization. World J Surg Oncol 2012, 10:73.
• [32]Diklic A, Zivaljevic V, Paunovic I, Krgovic K, Zivic R, Kazic M, Kalezic N, Tatic S, Havelka M, Bozic V: Lymphoma and other rare malignant tumors of the thyroid. Acta Chir Iugosl 2003, 50(3):141-146.
• [33]Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA: Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery 2009, 146(6):1105-1115.
• [34]Sarinah B, Hisham AN: Primary lymphoma of the thyroid: diagnostic and therapeutic considerations. Asian J Surg 2010, 33(1):20-24.
• [35]Matsuda M, Sone H, Koyama H, Ishiguro S: Fine-needle aspiration cytology of malignant lymphoma of the thyroid. Diagn Cytopathol 1987, 3(3):244-249.
• [36]Skarsgard ED, Connors JM, Robins RE: A current analysis of primary lymphoma of the thyroid. Arch Surg 1991, 126(10):1199-1203. discussion 1203–4
• [37]Das DK, Gupta SK, Francis IM, Ahmed MS: Fine-needle aspiration cytology diagnosis of non-Hodgkin lymphoma of thyroid: a report of four cases. Diagn Cytopathol 1993, 9(6):639-645.
• [38]Klyachkin ML, Schwartz RW, Cibull M, Munn RK, Regine WF, Kenady DE, McGrath PC, Sloan DA: Thyroid lymphoma: is there a role for surgery? Am Surg 1998, 64(3):234-238.
• [39]Seningen JL, Nassar A, Henry MR: Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001–2007: an institutional experience of 1,945 cases. Diagn Cytopathol 2012, 40(Suppl 1):E27-E32.
• [40]Sangalli G, Serio G, Zampatti C, Lomuscio G, Colombo L: Fine needle aspiration cytology of primary lymphoma of the thyroid: a report of 17 cases. Cytopathology 2001, 12(4):257-263.
• [41]Hwang YC, Kim TY, Kim WB, Shong YK, Yi KH, Shong M, Jo YS, Kim WS, Chung JH: Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J 2009, 56(3):399-405.
• [42]Listinsky CM: A practical approach to the diagnosis of Hodgkin lymphoma. Am J Clin Pathol 2002, 117(Suppl):S76-S94.
• [43]Aozasa K, Inoue A, Tajima K, Miyauchi A, Matsuzuka F, Kuma K: Malignant lymphomas of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors. Cancer 1986, 58(1):100-104.
• [44]Ansell SM: Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol 2012, 87(12):1096-1103.
• [45]Catrina Reading F, Schlette EJ, Stewart JM, Keating MJ, Katz RL, Caraway NP: Fine-needle aspiration biopsy findings in patients with small lymphocytic lymphoma transformed to hodgkin lymphoma. Am J Clin Pathol 2007, 128(4):571-578.
• [46]Fromm JR, Thomas A, Wood BL: Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity. Am J Clin Pathol 2009, 131(3):322-332.
• [47]Schmid S, Tinguely M, Cione P, Moch H, Bode B: Flow cytometry as an accurate tool to complement fine needle aspiration cytology in the diagnosis of low grade malignant lymphomas. Cytopathology 2011, 22(6):397-406.
• [48]Bangerter M, Brudler O, Heinrich B, Griesshamnuer M: Fine needle aspiration cytology and flow cytometry in the diagnosis and subclassification of non-Hodgkin’s lymphoma based on the World Health Organization classification. Acta Cytol 2007, 51(3):390-398.
• [49]Demurtas A, Accinelli G, Pacchioni D, Godio L, Novero D, Bussolati G, Palestro G, Papotti M, Stacchini A: Utility of flow cytometry immunophenotyping in fine-needle aspirate cytologic diagnosis of non-Hodgkin lymphoma: a series of 252 cases and review of the literature. Appl Immunohistochem Mol Morphol 2010, 18(4):311-322.
• [50]Liu K, Stern RC, Rogers RT, Dodd LG, Mann KP: Diagnosis of hematopoietic processes by fine-needle aspiration in conjunction with flow cytometry: a review of 127 cases. Diagn Cytopathol 2001, 24(1):1-10.
• [51]Chen HI, Akpolat I, Mody DR, Lopez-Terrada D, De Leon AP, Luo Y, Jorgensen J, Schwartz MR, Chang CC: Restricted kappa/lambda light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis. Am J Clin Pathol 2006, 125(1):42-48.
• [52]Martin-Subero JI, Klapper W, Sotnikova A, Callet-Bauchu E, Harder L, Bastard C, Schmitz R, Grohmann S, Hoppner J, Riemke J, Barth TF, Berger F, Bernd HW, Claviez A, Gesk S, Frank GA, Kaplanskaya IB, Moller P, Parwaresch RM, Rudiger T, Stein H, Kuppers R, Hansmann ML, Siebert R, Deutsche Krebshilfe Network Project Molecular Mechanisms in Malignant L: Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res 2006, 66(21):10332-10338.
• [53]Zeppa P, Cozzolino I, Peluso AL, Troncone G, Lucariello A, Picardi M, Carella C, Pane F, Vetrani A, Palombini L: Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis. Cancer 2009, 117(3):174-184.
• [54]Joos S, Kupper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M, Marynen P, Moller P, Pfreundschuh M, Trumper L, Lichter P: Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000, 60(3):549-552.
• [55]Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S, Mechtersheimer G, Trumper L, Moller P, Lichter P, Barth TF: Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002, 99(4):1381-1387.
• [56]Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI, Wolf J, Adamowicz M, Barth TF, Lichter P, Jauch A: Hodgkin’s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 2003, 103(4):489-495.
• [57]Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJ, Siebert R: Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002, 99(4):1474-1477.
• [58]Baschieri L, Castagna M, Fierabracci A, Antonelli A, Del Guerra P, Squartini F: Distribution of calcitonin- and somatostatin-containing cells in thyroid lymphoma and in Hashimoto’s thyroiditis. Appl Pathol 1989, 7(2):99-104.
• [59]Linch DC, Gosden RG, Tulandi T, Tan SL, Hancock SL: Hodgkin’s lymphoma: choice of therapy and late complications. Hematology Am Soc Hematol Educ Program 2000, 2000(no. 1):205-221. ASH Education Book January 1, 2000
• [60]Kuppers R, Engert A, Hansmann ML: Hodgkin lymphoma. J Clin Invest 2012, 122(10):3439-3447.
• [61]Kuppers R: New insights in the biology of Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2012, 2012:328-334.
• [62]Thomas RM: Hodgkin’s lymphoma presenting as an abscess in thyroid gland. Indian J Pathol Microbiol 2012, 55(1):122-124.
• [63]Raemaekers JM, van der Maazen RW: Hodgkin’s lymphoma: news from an old disease. Neth J Med 2008, 66(11):457-466.
• [64]Barros MH, Vera-Lozada G, Soares FA, Niedobitek G, Hassan R: Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Int J Cancer 2012, 131(5):1142-1152.